Q4/2020 12/31/2020 EPS -1.020 ZacksConsensus -0.760 ActVsEst (0.260) - Miss
Last clovis oncology, inc earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-irhome
| Impact snapshot | Event time: | CLVS | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
CLVS alerts
CLVS alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLVS alerts
High impacting Clovis Oncology, Inc news events
Weekly update
A roundup of the hottest topics
CLVS
News
- Clovis Oncology (<a href="https://www.marketbeat.com/stocks/NASDAQ/CLVS/price-target/">NASDAQ: CLVS</a>) had its price target lowered by analysts at HC Wainwright from $15.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q4 2020 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Clovis Oncology Announces 2020 Operating ResultsBusiness Wire
- Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23Business Wire
- Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual MeetingBusiness Wire
- More
CLVS
SEC Filings
- 3/3/21 - Form 4
- 3/3/21 - Form 4
- 3/3/21 - Form 4
- CLVS's page on the SEC website
- More